Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Tomaszow Mazowiecki – page 3

34 clinical trials in Tomaszow Mazowiecki, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Tomaszow Mazowiecki at a glance
34
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

34 trials in Tomaszow Mazowiecki

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:AstraZeneca AB

Biliary neoplasm+1

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dextrose Bp
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Irinotecan
  • Sponsor:Pharma Mar S.A.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Seagen Inc.
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Merck Sharp & Dohme LLC
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol Myers Squibb International Corporation
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Institut De Recherches Internationales Servier IRIS

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Tomaszow Mazowiecki

What the registry says about research in the country

01 Oncology - Lung Cancer

Groundbreaking research focusing on small-cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), evaluating novel therapeutic approaches and combination treatments.

  • Advanced stage lung cancer treatments
  • Immunotherapy combinations
  • Novel therapeutic agents

Multiple trials investigating durvalumab and other innovative compounds for improved patient outcomes.

02 Breast Cancer Research

Comprehensive studies targeting various types of breast cancer, including hormone receptor-positive, HER2-negative, and triple-negative variants.

  • Metastatic breast cancer treatments
  • Targeted therapies
  • Pre- and post-surgical interventions

Innovative approaches combining immunotherapy with targeted treatments for enhanced efficacy.

03 Gastrointestinal Oncology

Studies examining treatments for gastric cancer and colorectal cancer, with emphasis on targeted therapies and novel drug combinations.

  • Advanced gastric cancer treatments
  • Metastatic colorectal cancer therapies
  • HER2-targeted approaches

Focus on personalized treatment strategies based on specific biomarkers.

04 Immunology and Allergies

Research into allergic conditions and immunotherapy treatments, including studies on rhinoconjunctivitis and dust mite allergies.

  • Allergen-specific immunotherapy
  • Respiratory allergy treatments
  • Novel therapeutic approaches

Evaluation of innovative immunotherapy protocols for improved patient care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.